West Pharmaceutical Services Inc
WST - NEW YORK STOCK EXCHANGE, INC.
Industry: Life Sciences Tools & Services
Market Cap: 15.7 B
IPO Date: Jul 27, 1923
Country: US
Currency: USD
Shares Outstanding: 71.8 M
Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
6/27/2025
NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. . Such investors are advised to contact...
Source: Finnhub
West Pharmaceutical Services, Inc. Class Action: Levi & Korsinsky Reminds West Pharmaceutical Services Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 7, 2025 - WST
6/27/2025
Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West...
Source: Finnhub
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders
6/27/2025
NEW YORK, June 27, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. of a class action securities lawsuit. ...
Source: Finnhub
WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
6/26/2025
Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In West To Contact Him Directly To Discuss Their OptionsIf you suffered...
Source: Finnhub
WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus
6/26/2025
West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.
Source: Yahoo
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
6/26/2025
Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West...
Source: Finnhub
The Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
6/26/2025
NEW YORK, June 26, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. . ...
Source: Finnhub
WST Deadline: WST Investors with Losses in Excess of $100K Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
6/25/2025
NEW YORK, June 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor...
Source: Finnhub
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
6/25/2025
LOS ANGELES, June 25, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against West...
Source: Finnhub
Shareholders of West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST
6/24/2025
Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West...
Source: Finnhub
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST
6/23/2025
NEW YORK, June 23, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. . ...
Source: Finnhub
WST Deadline: WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
6/20/2025
NEW YORK, June 20, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor...
Source: Finnhub
West Pharmaceutical Services, Inc. (WST), Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
6/20/2025
LOS ANGELES, June 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to West Pharmaceutical Services, Inc. have opportunity to lead the...
Source: Finnhub
5 Insightful Analyst Questions From West Pharmaceutical Services’s Q1 Earnings Call
6/20/2025
West Pharmaceutical Services’ first quarter results drew a negative market response, despite the company surpassing Wall Street’s revenue and non-GAAP profit expectations. Management attributed the flat year-over-year sales to continued destocking in biologics components and a shift in demand to specific manufacturing sites, creating short-term supply constraints. CEO Eric Green highlighted that “solid contributions from GLP-1s and a reduced impact from industry-wide destocking” were positive fa
Source: Yahoo
Faruqi & Faruqi Reminds West Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
6/20/2025
Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses In West To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired...
Source: Finnhub
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST
6/20/2025
NEW YORK, June 20, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. of a class action securities lawsuit. ...
Source: Finnhub
3 Cash-Producing Stocks with Open Questions
6/19/2025
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Source: Yahoo
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors
6/17/2025
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors
Source: MarketWatch